Literature DB >> 2839263

Characterization of rat liver beta-adrenoceptors during perinatal development as determined by [125I]-iodopindolol radioligand binding assays.

K Snell1, C A Evans.   

Abstract

1. The subtype specificity of beta-adrenoceptors in foetal (20 days post coitum) rat liver membrane preparations has been determined by use of [125I]-iodopindolol binding assays and the characteristics of radioligand binding have been resolved. 2. The kinetics of radioligand association and dissociation (in the presence of 5 x 10(-4) M isoprenaline) showed an association rate constant of 1.5 x 10(7) M-1 S-1 and dissociation rate constant of 9.1 x 10(-4) S-1, corresponding to a dissociation constant for [125I]-iodopindolol of 60.7 pM. A similar dissociation constant (75 pM) was determined by saturation binding assays. 3. The rank order of potency for displacement of [125I]-iodopindolol binding was consistent with binding to a predominantly beta 2-adrenoceptor population (i.e. ICI 118551 greater than isoprenaline greater than adrenaline greater than noradrenaline greater than atenolol). Computer analysis of displacement curves in the presence of a beta 1-subtype selective agent (atenolol) or a beta 2-subtype selective agent (ICI 118551) revealed the presence of beta 2- and beta 1-adrenoceptor subtypes in a ratio of about 80:20%. 4. Saturation binding assays by use of [125I]-iodopindolol were carried out at different perinatal ages to determine total beta-adrenoceptor concentrations and beta 2-subtype (in the presence of 5 x 10(-7) M atenolol) adrenoceptor concentrations. Competition binding assays with atenolol confirmed that at all ages apparent beta 2-adrenoceptor binding accounted for 84-95% of the total beta-adrenoceptor binding. The total beta- and beta 2-adrenoceptor binding capacity increased by 2.3 fold from 20 days post coitum to birth, and then decreased postnatally at 1 and 2 days post partum. The dissociation constant for [125I]-iodopindolol binding did not show any change with age. 5. The change in beta 2-adrenoceptor concentration with age is discussed in relation to the changing beta-adrenoceptor-mediated responsiveness of glucose production by rat liver during perinatal development.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839263      PMCID: PMC1853877          DOI: 10.1111/j.1476-5381.1988.tb11467.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Development of insulin and glucagon binding and the adenylate cyclase response in liver membranes of the prenatal, postnatal, and adult rat: evidence of glucagon "resistance".

Authors:  E Blazquez; B Rubalcava; R Montesano; L Orci; R H Unger
Journal:  Endocrinology       Date:  1976-04       Impact factor: 4.736

2.  Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies.

Authors:  E L Rugg; D B Barnett; S R Nahorski
Journal:  Mol Pharmacol       Date:  1978-11       Impact factor: 4.436

3.  Adrenergic control of glucose output and adenosine 3':5'-monophosphate levels in hepatocytes from juvenile and adult rats.

Authors:  J B Blair; M E James; J L Foster
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

4.  Acute hormonal regulation of cyclic AMP content and glycogen phosphorylase activity in fetal liver in organ culture.

Authors:  P Sherline; H Eisen; W Glinsmann
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

5.  Specific and unspecific binding of [3H](--)dihydroalprenolol to cardiac tissue.

Authors:  W Krawietz; E Erdmann
Journal:  Biochem Pharmacol       Date:  1979-04-15       Impact factor: 5.858

6.  Time-dependent conversion of alpha 1- to beta-adrenoceptor-mediated glycogenolysis in isolated rat liver cells: role of membrane phospholipase A2.

Authors:  G Kunos; F Hirata; E J Ishac; L Tchakarov
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  Beta-adrenergic receptors and cyclic adenosine monophosphate generation in human fetal lung.

Authors:  D J Davis; B J Dattel; P L Ballard; J M Roberts
Journal:  Pediatr Res       Date:  1987-02       Impact factor: 3.756

9.  Glucose metabolism in the newborn rat: the role of insulin.

Authors:  K Snell; D G Walker
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

10.  Cytomorphometry of developing rat liver and its application to enzymic differentiation.

Authors:  O Greengard; M Federman; W E Knox
Journal:  J Cell Biol       Date:  1972-02       Impact factor: 10.539

View more
  2 in total

1.  Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C.

Authors:  W T Kassahun; B Günl; A Tannapfel; F R Ungemach; J Hauss; G Abraham
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-15       Impact factor: 3.000

2.  Effects of lactation on the regulation of hepatic metabolism in the rat and sheep: adrenergic receptors and cyclic AMP responses.

Authors:  A M Dunphy; K Snell; R A Clegg
Journal:  Mol Cell Biochem       Date:  1992-11-04       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.